Janney Montgomery Scott
TXG icon

Janney Montgomery Scott’s 10x Genomics TXG Stock Holding History

Janney Montgomery Scott’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,146
Closed -$414K – 2608
2022
Q2 		$414K Sell
9,146
-4,821
-35% -$250K ﹤0.01% 1708
2022
Q1 		$1.06M Buy
13,967
+7,807
+127% +$683K ﹤0.01% 1217
2021
Q4 		$918K Buy
6,160
+4,734
+332% +$725K ﹤0.01% 1383
2021
Q3 		$208K Buy
+1,426
New +$245K ﹤0.01% 2150

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janney Montgomery Scott's TXG Position: Q3 2022 in Review

Janney Montgomery Scott sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 9,146 shares — an estimated $414K sold.

Janney Montgomery Scott first reported a position in TXG in Q3 2021 and held it in 4 quarters. The position peaked at $1.06M in Q1 2022. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • Janney Montgomery Scott reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 9,146 10x Genomics shares in Q3 2022, an estimated $414K.
  • Janney Montgomery Scott first reported a position in 10x Genomics in Q3 2021 and held it in 4 quarters.
  • Janney Montgomery Scott's 10x Genomics position peaked at $1.06M in Q1 2022.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on Janney Montgomery Scott's 13F filing for Q3 2022, filed 25 Oct 2022.